https://clinicaltrials.gov/ct2/show/NCT02349061?type=Intr&cond=Lupus&phase=012345&lupd_s=02%2F11%2F2019&lupd_d=14
Condition : Lupus Erythematosus, Systemic
Interventions : Drug: Ustekinumab IV; Drug: Placebo Infusion; Drug: Placebo SC; Drug: Ustekinumab SC; Other: Concomitant Medication
Sponsor : Janssen Research & Development, LLC
Active, not recruiting
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
NCT02349061
Wed, 28 Jan 2015 12:00:00 EST
